Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

1.

[The effect of the cerebrospinal fluid from patients with manic and depressive syndromes on the social hierarchical relationships in a group of rats].

Zhdanova IV, Tokarev AV.

Zh Vyssh Nerv Deiat Im I P Pavlova. 1990 May-Jun;40(3):558-64. Russian.

PMID:
2169163
2.
3.
4.

[Effect of the cerebrospinal fluid of manic-depressive psychosis patients on the self-stimulation reaction].

Vartanian GA, Zhdanova IV, Lebedev AA, Petrov ES.

Fiziol Cheloveka. 1985 Nov-Dec;11(6):980-3. Russian. No abstract available.

PMID:
4076693
5.

Endorphins in human cerebrospinal fluid: clinical correlations to some psychotic states.

Lindström LH, Widerlöv E, Gunne LM, Wahlström A, Terenius L.

Acta Psychiatr Scand. 1978 Feb;57(2):153-64.

PMID:
636907
6.

[Specific neurohumoral activity of the cerebrospinal fluid of patients with manic-depressive psychosis].

Vartanian GA, Zhdanova IV, Petrov ES.

Fiziol Cheloveka. 1986 Jan-Feb;12(1):167-70. Russian. No abstract available.

PMID:
2870946
7.

Relationship of white matter hyperintensities to cerebrospinal fluid glucose polyol pathway metabolites-a pilot study in treatment-resistant affective disorder patients.

Regenold WT, Hisley KC, Obuchowski A, Lefkowitz DM, Marano C, Hauser P.

J Affect Disord. 2005 Apr;85(3):341-50.

PMID:
15780705
8.

Is puerperal psychosis the same as bipolar manic-depressive disorder? A family study.

Dean C, Williams RJ, Brockington IF.

Psychol Med. 1989 Aug;19(3):637-47.

PMID:
2798633
10.

Endorphins in the cerebrospinal fluid of psychiatric patients.

Pickar D, Naber D, Post RM, van Kammen DP, Kaye W, Rubinow DR, Ballenger JC, Bunney WE Jr.

Ann N Y Acad Sci. 1982;398:399-412.

PMID:
6297360
11.

The significance of psychotic features in manic episodes: a report from the NIMH collaborative study.

Coryell W, Leon AC, Turvey C, Akiskal HS, Mueller T, Endicott J.

J Affect Disord. 2001 Dec;67(1-3):79-88.

PMID:
11869754
12.

[An ethological model of endogenous psychoses].

Vieira AB.

Acta Psychiatr Belg. 1991 Jul-Oct;91(4-5):232-42. French.

PMID:
1670418
13.

[Low-dose (0.5 mg) DST in manic and major depressive episodes: in relation to the severity of symptoms].

Matsunaga H, Sarai M.

Seishin Shinkeigaku Zasshi. 2000;102(4):367-98. Review. Japanese.

PMID:
10892305
14.

Diagnostic value of the DSM and ICD categories of psychosis: an evidence-based approach. UK700 Group.

van Os J, Gilvarry C, Bale R, van Horn E, Tattan T, White I, Murray R.

Soc Psychiatry Psychiatr Epidemiol. 2000 Jul;35(7):305-11.

PMID:
11016525
15.

Acid metabolites and precursor amino acids of 5-hydroxytryptamine and dopamine in affective and other psychiatric disorders.

Korf J, van den Burg W, van den Hoofdakker RH.

Psychiatr Clin (Basel). 1983;16(1):1-16.

PMID:
6189146
16.

Vulnerability to psychosis increases the risk of depression. Results of the RADEP study.

Salokangas RK, Luutonen S, Nieminen M, Huttunen J, Karlsson H.

Nord J Psychiatry. 2007;61(5):393-402.

PMID:
17990202
17.

Dimensions underlying outcome criteria in bipolar I disorder.

Brieger P, Röttig S, Röttig D, Marneros A, Priebe S.

J Affect Disord. 2007 Apr;99(1-3):1-7. Epub 2006 Sep 22.

PMID:
16996137
18.

Cerebrospinal fluid total protein in patients with affective disorders.

Pazzaglia PJ, Post RM, Rubinow D, Kling MA, Huggins TS, Sunderland T.

Psychiatry Res. 1995 Aug 28;57(3):259-66.

PMID:
7501736
19.

Lack of effect of carbamazepine on gamma-aminobutyric acid in cerebrospinal fluid.

Post RM, Ballenger JC, Hare TA, Bunney WE Jr.

Neurology. 1980 Sep;30(9):1008-11.

PMID:
7191529
20.

Functional impairment in the remission phase of bipolar disorder.

Fagiolini A, Kupfer DJ, Masalehdan A, Scott JA, Houck PR, Frank E.

Bipolar Disord. 2005 Jun;7(3):281-5.

PMID:
15898966

Supplemental Content

Support Center